StockDuty ← Dashboard Aug 28, 2026 07:17 PM ET
CatalystFDA/Bio

BIONTECH HALTS MRNA COLORECTAL CANCER VACCINE TRIAL AFTER SAFETY REVIEW - REUTERS - GNEWS

Termination of mid-stage trial signals negative efficacy data for BioNTech's mRNA cancer vaccine.

What changed
Why it matters
Termination of mid-stage trial signals negative efficacy data for BioNTech's mRNA cancer vaccine.
Sources
gnews
Related signals
PHASE 1 OF INDIA - US TRADE PACT HINGES ON SECTION 301 PROBE , OFFICIAL SAYS →PITNEY BOWES OUTLINES PHASE 2 STRATEGIC REVIEW WHILE PUSHING NEAREST DEBT MATURITY TO MARCH 2029 - SEEKINGALPHA →UNICYCIVE PLUMMETS FOLLOWING SECOND CRL FOR OLC FOR HYPERPHOSPHATEMIA - SEEKINGALPHA →